Literature DB >> 23410758

Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder.

Michael R Jarcho1, George M Slavich, Hana Tylova-Stein, Owen M Wolkowitz, Heather M Burke.   

Abstract

Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is believed to play a role in the pathophysiology of depression. To investigate mechanisms that may underlie this effect, we examined several indices of HPA axis function - specifically, diurnal cortisol slope, cortisol awakening response, and suppression of cortisol release following dexamethasone administration - in 26 pre-menopausal depressed women and 23 never depressed women who were matched for age and body mass index. Salivary cortisol samples were collected at waking, 30 min after waking, and at bedtime over three consecutive days. On the third day, immediately after the bedtime sample, participants ingested a 0.5mg dexamethasone tablet; they then collected cortisol samples at waking and 30 min after waking the following morning. As predicted, depressed women exhibited flatter diurnal cortisol rhythms and more impaired suppression of cortisol following dexamethasone administration than non-depressed women over the three sampling days. In addition, flatter diurnal cortisol slopes were associated with reduced cortisol response to dexamethasone treatment, both for all women and for depressed women when considered separately. Finally, greater self-reported depression severity was associated with flatter diurnal cortisol slopes and with less dexamethasone-related cortisol suppression for depressed women. Depression in women thus appears to be characterized by altered HPA axis functioning, as indexed by flatter diurnal cortisol slopes and an associated impaired sensitivity of cortisol to dexamethasone. Given that altered HPA axis functioning has been implicated in several somatic conditions, the present findings may be relevant for understanding the pathophysiology of both depression and depression-related physical disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410758      PMCID: PMC3687535          DOI: 10.1016/j.biopsycho.2013.01.018

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  68 in total

1.  Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine.

Authors:  W J Inder; T C Prickett; R T Mulder; R A Donald; P R Joyce
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

Review 2.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

3.  Discrimination and the stress response: psychological and physiological consequences of anticipating prejudice in interethnic interactions.

Authors:  Pamela J Sawyer; Brenda Major; Bettina J Casad; Sarah S M Townsend; Wendy Berry Mendes
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

4.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

5.  Severe life events predict specific patterns of change in cognitive biases in major depression.

Authors:  Scott M Monroe; George M Slavich; Leandro D Torres; Ian H Gotlib
Journal:  Psychol Med       Date:  2007-04-04       Impact factor: 7.723

Review 6.  Black sheep get the blues: a psychobiological model of social rejection and depression.

Authors:  George M Slavich; Aoife O'Donovan; Elissa S Epel; Margaret E Kemeny
Journal:  Neurosci Biobehav Rev       Date:  2010-01-18       Impact factor: 8.989

Review 7.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

8.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

9.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

10.  Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.

Authors:  M J Bradbury; S F Akana; M F Dallman
Journal:  Endocrinology       Date:  1994-03       Impact factor: 4.736

View more
  46 in total

1.  Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.

Authors:  M N Edelmann; C A Sandman; L M Glynn; D A Wing; E P Davis
Journal:  Psychoneuroendocrinology       Date:  2016-06-23       Impact factor: 4.905

2.  Altered stress patterns and increased risk for postpartum depression among low-income pregnant women.

Authors:  Kathryn Scheyer; Guido G Urizar
Journal:  Arch Womens Ment Health       Date:  2015-08-15       Impact factor: 3.633

Review 3.  Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders.

Authors:  George M Slavich; Julia Sacher
Journal:  Psychopharmacology (Berl)       Date:  2019-07-29       Impact factor: 4.530

4.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

Review 5.  From stress to inflammation and major depressive disorder: a social signal transduction theory of depression.

Authors:  George M Slavich; Michael R Irwin
Journal:  Psychol Bull       Date:  2014-01-13       Impact factor: 17.737

Review 6.  Psychosocial functioning and the cortisol awakening response: Meta-analysis, P-curve analysis, and evaluation of the evidential value in existing studies.

Authors:  Ian A Boggero; Camelia E Hostinar; Eric A Haak; Michael L M Murphy; Suzanne C Segerstrom
Journal:  Biol Psychol       Date:  2017-09-14       Impact factor: 3.251

7.  Possible Contribution of PTSD to Altered Cortisol Activity in Young Adult Obese African-American Women.

Authors:  Teletia R Taylor; Kendra Van Kirk; Denia Tapscott; Monet Bernard; Juliana Llano; Thomas A Mellman
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-06

Review 8.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

9.  Early life stress and HPA axis function independently predict adult depressive symptoms in metropolitan Cebu, Philippines.

Authors:  Andrew Wooyoung Kim; Emma K Adam; Sonny A Bechayda; Christopher W Kuzawa
Journal:  Am J Phys Anthropol       Date:  2020-08-03       Impact factor: 2.868

10.  A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults.

Authors:  Natalia O Dmitrieva; David M Almeida; Julia Dmitrieva; Eric Loken; Carl F Pieper
Journal:  Psychoneuroendocrinology       Date:  2013-06-14       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.